Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.94 is 36% below its 5-year average of 7.79, near the low end of its 5-year range (4.86–19.24).
As of the fiscal period ended Tuesday, June 30, 2026. 4.68% below its 12-month average of 5.19.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.94.
CURRENT RATIO
4.94
CURRENT RATIO AVG TTM
5.19
CURRENT RATIO AVG 3Y
5.85
CURRENT RATIO AVG 5Y
7.79
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.68%
CURRENT VS 3Y AVG
-15.54%
CURRENT VS 5Y AVG
-36.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.74
median of 852 covered companies
CURRENT VS SECTOR MEDIAN
+32.38%
vs the sector median at left
Market Cap
$445.64M
Current Ratio
6.72
TTM Avg
10.04
3Y Avg
13.74
5Y Avg
16.43
Market Cap
$444.69M
Current Ratio
12.39
TTM Avg
8.12
3Y Avg
11.14
5Y Avg
10.14
Market Cap
$441.97M
Current Ratio
7.35
TTM Avg
8.39
3Y Avg
5.06
5Y Avg
6.73
Market Cap
$433.90M
Current Ratio
13.99
TTM Avg
3.82
3Y Avg
4.25
5Y Avg
5.96
Market Cap
$432.39M
Current Ratio
22.29
TTM Avg
19.64
3Y Avg
11.19
5Y Avg
11.30
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroPace, Inc. (NPCE) | $446.29M | 4.94 | 5.19 | 5.85 | 7.79 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $445.64M | 6.72 | 10.04 | 13.74 | 16.43 |
| Ovid Therapeutics Inc. (OVID)vs › | $444.69M | 12.39 | 8.12 | 11.14 | 10.14 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $441.97M | 7.35 | 8.39 | 5.06 | 6.73 |
| NRC Health (NRC)vs › | $457.04M | 0.65 | 0.55 | 0.77 | 1.10 |
| Assembly Biosciences, Inc. (ASMB)vs › | $433.90M | 13.99 | 3.82 | 4.25 | 5.96 |
| Tectonic Therapeutic, Inc. (TECX)vs › | $432.39M | 22.29 | 19.64 | 11.19 | 11.30 |
| Editas Medicine, Inc. (EDIT)vs › | $430.34M | 3.19 | 3.65 | 4.66 | 6.11 |
| NeoGenomics, Inc. (NEO)vs › | $428.59M | 3.60 | 3.12 | 4.79 | 5.52 |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | 4.95 | 9.63 | 11.08 | 12.07 |
Current Ratio
4.94
Quick Ratio
3.91
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.94 |
| 2026-03-31 | 5.38 |
| 2025-12-31 | 5.28 |
| 2025-09-30 | 4.86 |
| 2025-06-30 | 5.47 |
| 2025-03-31 | 6.63 |
| 2024-12-31 | 5.37 |
| 2024-09-30 | 5.59 |
| 2024-06-30 | 6.37 |
| 2024-03-31 | 6.43 |
| 2023-12-31 | 5.71 |
| 2023-09-30 | 6.55 |
| 2023-06-30 | 7.52 |
| 2023-03-31 | 9.13 |
| 2022-12-31 | 8.90 |
| 2022-09-30 | 11.08 |
| 2022-06-30 | 9.86 |
| 2022-03-31 | 10.15 |
| 2021-12-31 | 14.28 |
| 2021-09-30 | 16.20 |
| 2021-06-30 | 19.24 |
| 2021-03-31 | 4.36 |
| 2020-12-31 | 5.69 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
